Seattle’s Allen Institute is contributing to a pioneering space mission that could reshape the future of medicine. This weekend, stem cells supplied by the Allen Institute for Cell Science are set to launch aboard a SpaceX Falcon 9 rocket, marking the first attempt to grow heart and brain organoids in space.
The effort is being led by Cedars-Sinai researchers in Los Angeles, who believe that studying organoids, tiny, three-dimensional clusters of cells that replicate the behavior of real organs, beyond Earth’s gravity could unlock new insights into conditions such as ALS, Parkinson’s, and cardiovascular disease. On Earth, gravity constrains how these clusters develop. Scientists hope the microgravity of space will allow organoids to form more complex structures, possibly even blood vessels, offering a clearer model for disease and potential treatments.